What Is The Current and Historic Market Size Analysis Of Direct-To-Consumer (DTC) Genetic Testing Market?
The direct-to-consumer (dtc) genetic testing market has seen considerable growth due to a variety of factors.
• In the past few years, the direct-to-consumer (DTC) genetic testing market has experienced a significant expansion. The market, which was valued at $1.84 billion in 2024, is projected to increase to $2.14 billion in 2025, showing a compound annual growth rate (CAGR) of 16.2%.
The historical growth can be credited to factors such as interest in lineage and heritage, health and wellness movements, marketing and consumer awareness, the desire for privacy and control of genetic data, and low cost and easy availability.
What Is The Projected Growth Of The Direct-To-Consumer (DTC) Genetic Testing Market?
The direct-to-consumer (dtc) genetic testing market is expected to maintain its strong growth trajectory in upcoming years.
• Expected to exhibit rapid expansion in the impending years, the direct-to-consumer (DTC) genetic testing market is on track to grow at a compound annual growth rate (CAGR) of 16.2% reaching a value of $3.9 billion by 2029. Factors driving growth in the forecast period include an increase in the range of testing options, encapsulation with personalized medicine, partnerships with health and wellness sectors, advances in genetic study, and government backing and regulations. Trends that will cause the growth during the forecast period encompass enlarging test selections and panels, customer educational efforts, observation and alignment with regulations, genomic data investigation and inputs, and declining prices and increased availability.
Which Drivers Are Accelerating Growth In The Direct-To-Consumer (DTC) Genetic Testing Market?
The surge in diseases and disorders that can be genetically transmitted is anticipated to boost the growth of the direct-to-consumer (DTC) genetic testing market. Genetic disorders are diseases triggered by alterations (mutations) in an individual's DNA, and they include single-gene, multifactorial, and chromosomal disorders. DTC genetic testing increases awareness about these disorders by offering personalized data about a person's health, disease risk, and other characteristics, which, in turn, assists in making informed health and lifestyle choices to reduce disease risk. For instance, the National Library of Medicine (NLM), a US medical library, noted in April 2023 that an estimated 6.7 million Americans aged 65 and above will be diagnosed with Alzheimer's dementia (AD), a disease significantly influenced by genetics, in 2023. This figure could escalate to 13.8 million by 2060 if no medical advancements are made to prevent, slow, or cure AD. As a result, the surging prevalence of diseases and disorders that can be passed on genetically is fuelling the expansion of the direct-to-consumer (DTC) genetic testing market.
What Are The Principal Market Segments In The Global Direct-To-Consumer (DTC) Genetic Testing Healthcare Industry?
The direct-to-consumer (DTC) genetic testing market covered in this report is segmented –
1) By Type: Carrier Testing, Predictive Testing, Ancestry And Relationship Testing, Nutrigenomic Testing, Other Types
2) By Sample: Saliva, Urine, Blood
3) By Technology: Single Nucleotide Polymorphism Chips, Whole Genome Sequencing, Targeted Analysis
4) By Business Model: Health Planning Model, Comprehensive Genome Tests Model, Medical Precision Tests Model, Restricted Trait Tests Mode
5) By End User: Laboratories, Blood Banks, Nursing Homes, Hospitals, Imaging Centers, Home Care, Cosmetics, Other End-User
Subsegments:
1) By Carrier Testing: Autosomal Recessive Disorders, X-Linked Disorders
2) By Predictive Testing: Risk Assessment For Genetic Conditions, Adult-Onset Conditions
3) By Ancestry And Relationship Testing: Ancestry Composition Analysis, DNA Matching For Relationships
4) By Nutrigenomic Testing: Dietary Recommendations, Metabolism And Fitness Insights
5) By Other Types: Pharmacogenomic Testing, Health Trait Testing
Pre-Book The Direct-To-Consumer (DTC) Genetic Testing Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Market Trends Are Altering The Direct-To-Consumer (DTC) Genetic Testing
Leading firms in the direct-to-consumer (DTC) genetic testing landscape are concentrating their efforts on funneling their investments into genetic research to maintain their market stronghold. A robust financial foothold allows these genetic testing firms to carry out extensive research, advance their technological attributes, broaden their market span, assure regulatory compliance, and foster innovation. As a case in point, Redcliffe Labs, a diagnostic center and lab-based entity in India, declared in November 2022 their plans to channel an extra $10 million (approximately Rs 81 crore) to escalate its genetic and specialized testing array. This infusion of funds is mapped out to spur the progress of the company's genetic testing proficiency, spanning prenatal, oncology, neurology, nephrology, and pharmacogenomics. The firm has previously designated $6 million to genetics and specialized testing domain and is zeroing in on next-generation technologies in the diagnostic arena.
Who Are the Key Players in the Direct-To-Consumer (DTC) Genetic Testing Market?
Major companies operating in the direct-to-consumer (DTC) genetic testing market include:
• 23andMe
• AncestryDNA
• MyHeritage
• FamilyTreeDNA
• Living DNA
• Vitagene
• Orig3n
• DNAfit
• Helix
• Color Genomics
• Circle DNA
• CRI Genetics
• MapMyGenome
• Invitae Corporation
• TellmeGen
• Pathway Genomics
• Genebase Systems
• EasyDNA
• Nebula Genomics
• Dante Labs
• Veritas Genetics
• Xcode Life
• Genomic Express
• Genomelink
• Genomind
• WellnessFX
• LetsGetChecked
• iGene
• Dnadoc
• OneOme
What are the Regional Insights into the Direct-To-Consumer (DTC) Genetic Testing Market?
North America was the largest region in the direct-to-consumer (DTC) genetic testing market share in 2024. Asia-Pacific was the second-largest region in the global direct-to-consumer (DTC) genetic testing market. The regions covered in the direct-to-consumer (dtc) genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
